Source: International Congress 2018 – Respiratory medicine meets rheumatology



Rating:

Share or cite this content

Citations should be made in the following way:
C. Kelly (Gateshead, United Kingdom). The chicken or the egg: drug-induced pulmonary disease in rheumatology. International Congress 2018 – Respiratory medicine meets rheumatology

Member's Comments

No comment yet.

Related content which might interest you: Idiopathic pulmonary fibrosis and systemic sclerosis-interstitial lung disease: features at admission to a tertiary pulmonology unit. Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Developing the pulmonary rehabilitation model for chronic heart disease Source: Annual Congress 2010 - PG22 Postgraduate Course: Developing pulmonary rehabilitation in non-COPD patients Year: 2010 Prevalence of chronic ischaemic heart disease in idiopathic pulmonary fibrosis: A single center study Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Early origins of chronic pulmonary disease: the role of the adult pulmonologist Source: Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine Year: 2020 Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19. Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021 Interdisciplinary rehabilitation in pulmonary hypertension: can we learn from chronic obstructive pulmonary disease or heart failure? Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure Year: 2018 Congenital heart disease and pulmonary hypertension (cardiology for pulmonologists) Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Bronchial inflammation, respiratory symptoms and lung function in patients who finished treatment for pulmonary tuberculosis: is it the beginning of a new disease? Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Respiratory medicine meets rheumatology: What is new in connective tissue diseases – ILD Source: ERS webinar 2021: Respiratory medicine meets rheumatology: What is new in connective tissue diseases – ILD Year: 2021 Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant? Source: ERJ Open Res 2015; 1: 00050-2015 Year: 2015 Pattern and impact of rheumatology referral in patients with ILD and autoimmune features Source: International Congress 2016 – Connective tissue disorders Year: 2016 Differing clinical courses of IPF at an acute district general hospital Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Magnetic stimulation for the measurement of respiratory and skeletal muscle function Source: Eur Respir J 2004; 24 : 846-860 Year: 2004 Morphologic evaluation of lung in a scleroderma-like rabbit model Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006 Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013